New Alzheimer's drug trial, heat deaths, and other health stories you need to know about
A new Alzheimer's drug, donanemab, has been shown to slow cognitive decline in patients in a global trial by 35%.
Dr. Shyam Bishen is a senior healthcare executive with over 25 years of global experience in healthcare public-private partnership, strategy development, M&A, and business development. He comes to the Forum from Bill and Melinda Gates Foundation in Seattle where he was a regional/deputy director for seven years and was responsible for partnering to harness advances in healthcare to save lives. Before moving to Gates Foundation, he spent more than 20 years in private sector, and most recently headed up emerging markets strategy & innovation at Merck (MSD) in New Jersey as vice president and general manager. Prior to joining the corporate sector, Dr. Bishen was in academia and worked as an Assistant Professor at the Medical University of South Carolina in Charleston. He is qualified with a Ph.D. from the University of Newcastle and an MBA from Washington University in St. Louis.
A new Alzheimer's drug, donanemab, has been shown to slow cognitive decline in patients in a global trial by 35%.
A health alert has been issued in the US after a handful of locally transmitted cases of malaria were identified in the country. The cases in Texas and Florida are the first to have sprea...
From predicting which patients are most likely to develop heart disease to creating personalised cancer vaccines, artificial intelligence (AI) is adding new capabilities to the health sec...
La brecha mundial de género en materia de salud y supervivencia ha mejorado el pasado año, y es una de las más estrechas medidas por el Informe sobre la Brecha de Género 2023 del Foro Eco...
The global gender gap on health and survival has improved year-on-year, and is one of the narrowest gaps measured by the World Economic Forum's Gender Gap Report 2023.
A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has seen positive results against five strains of meningococcal bacteria – A, C, W, Y an...
The World Health Assembly (WHA) is an annual event in Geneva, Switzerland, that the World Health Organization’s (WHO) decision-making body holds to convene WHO member states to determine ...
The World Health Organization (WHO) has declared that the outbreak of the Mpox virus which began around a year ago is no longer a public health emergency of international concern.
The World Health Organization (WHO) ended the global emergency status for COVID-19 on 5 May, more than three years after its original declaration, and said countries should now manage the...
Nigeria and Ghana have become the first countries in the world to back a new malaria shot. The R21 vaccine has been developed by scientists at Oxford University and manufactured by the Se...
“The COVID-19 pandemic has been a disaster for childhood immunization.”
Una marea de datos sanitarios y tecnologías digitales -como la inteligencia artificial (IA) y la telemedicina- está barriendo prejuicios arraigados sobre la salud mundial y el acceso y la...
The US government is spending over $5 billion to speed up the development of new COVID-19 vaccines and treatments. 'Project NextGen' aims to provide better protection from coronaviruses, ...
A tide of health data and digital technologies – such as artificial intelligence (AI) and telemedicine – is sweeping away long-held preconceptions about global health and healthcare acces...
The COVID-19 pandemic presented the biggest test our modern global healthcare systems have ever seen. It revealed stark inequalities and systemic issues, leaving many systems scarred and ...









